GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What Happens Here Matters Everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Amgen

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune… Read More

Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu

Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based… Read More

Amgen and University of Washington’s Institute for Protein Design team up to build better cancer drugs

Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington’s… Read More

Alder BioPharmaceuticals raises $170M in stock offering as FDA reviews its migraine therapy

Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application… Read More

Expedia starts renovating old lab buildings on Seattle campus ahead of 2019 move

Expedia isn’t coming to Seattle until 2019, but crews have already begun demolishing old lab space at the company’s future 40-acre Seattle… Read More

Gates Foundation leads $14M funding round for Just Biotherapeutics to battle infectious diseases

Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation.… Read More

First look: Expedia unveils designs for huge Seattle waterfront campus

Nearly a year ago, Mark Nagle was on the hunt for a location that could serve as Expedia’s new headquarters. He found himself… Read More

Expedia pushes back target date for Seattle move until 2019, will test new commuter shuttle

Expedia says it won’t be making its much-anticipated move to Seattle until 2019, a development that gives the company a little more time… Read More

Inside Expedia’s expansion plans: New Seattle campus could hold up to 12,000 workers by 2030

Expedia is pulling back the curtain on its long-term vision for the 40-acre site the company bought for its new Seattle… Read More

Expedia lays groundwork for giant expansion of future Seattle waterfront headquarters

Expedia’s new waterfront headquarters in Seattle could one day grow into a 1.6 million-square-foot campus, according to transit planning documents obtained by… Read More

Novo Nordisk cutting workforce, focusing efforts on diabetes treatments

Here’s another dose of bad news for Seattle’s biotech industry. Novo Nordisk this week announced plans to discontinue R&D efforts… Read More

Podcast

GeekWire Radio: Amgen and the state of Seattle biotech, with guest Luke Timmerman

Amgen dealt a blow to Seattle’s biotech industry last week with the announcement that it will be closing its large research-and-development campus… Read More

Podcast

GeekWire Radio: Food’s here! Our favorite new meal delivery services and apps

For anyone interested in having meals delivered to the home or office, there’s a smorgasbord of new options these days —… Read More

Amazon’s new waterfront home? Five ideas for Amgen’s beautiful Seattle campus

News that Amgen plans to shutter its 40-acre campus along Elliott Bay marks yet another setback for Seattle’s biotech industry,… Read More

Amgen to shutter giant Seattle waterfront campus

Biotech giant Amgen says it will close its facilities in the Seattle region — including its 40-acre waterfront campus on Elliott Bay, inherited… Read More

A Word From Our Sponsors

About

  • About GeekWire
  • Contact Us
  • Partner With Us
  • Become a GeekWire Member
  • Send Us a Tip
  • Join Our Startup List
  • Reprints and Permissions

Follow

  • Facebook
  • X
  • LinkedIn
  • Instagram
  • RSS Feed
  • Podcast
  • YouTube
  • Bluesky

GeekWire Newsletters

Catch every headline in your inbox

Read GeekWire

  • Apple News
  • Google News

Legal

  • Privacy Policy
  • Terms of Use
  • Sponsored Content Policy
Return to Top of Page
© 2011-2025 GeekWire, LLC
Do Not Sell or Share My Personal information
Limit the Use Of My Sensitive Personal Information
Consent Preferences